Cargando…
Anti-cancer oncolytic activity of respiratory syncytial virus
Oncolytic virotherapy is an emerging bio-therapeutic platform for cancer treatment, which is based on selective infection/killing of cancer cells by viruses. Herein we identify the human respiratory syncytial virus (RSV) as an oncolytic virus. Using prostate cancer models, we show dramatic enhanceme...
Autores principales: | Echchgadda, I, Kota, S, Cruz, I DeLa, Sabbah, A, Chang, T, Harnack, R, Mgbemena, V, Chatterjee, B, Bose, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813688/ https://www.ncbi.nlm.nih.gov/pubmed/19444304 http://dx.doi.org/10.1038/cgt.2009.34 |
Ejemplares similares
-
Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense
por: Echchgadda, Ibtissam, et al.
Publicado: (2011) -
Krüppel-like factor 6 regulates transforming growth factor-β gene expression during human respiratory syncytial virus infection
por: Mgbemena, Victoria, et al.
Publicado: (2011) -
TLR2/MyD88/NF-κB Pathway, Reactive Oxygen Species, Potassium Efflux Activates NLRP3/ASC Inflammasome during Respiratory Syncytial Virus Infection
por: Segovia, Jesus, et al.
Publicado: (2012) -
Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
por: Suzuki, Takuma, et al.
Publicado: (2021) -
The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431
por: Salimi, Vahid, et al.
Publicado: (2013)